Pharmacist graduated at Unesp (2000). Master in Biotechnology at USP (2004), PhD in science at the University of São Paulo and University of Strasbourg (2009) and MBA in management of innovation in health from Instituto Butantan. Has scientific production in the recombinant expression area using insect and mammalian cells. He was granted by different agencies for the development of scientific projects in the field of biotechnology and viral vaccines. His current work is focused in the development of viral vaccines with enfasis in new vaccines. He is the current director of Multipurpose Laboratory at Instituto Butantan and institutional representative in GLOPID-R and Vax-Hub international networks. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
The Butantan Institute is strongly committed to public health and, therefore, to actions related to combating COVID-19. The sectors or centers of the Butantan Institute, namely the Development and Innovation Center, the Scientific Development Center, the Bioindustrial Development Center and the Cultural Development Center, came together to develop projects to fight the pandemic. Consideri…
Rabies control is one of the global health challenges. While under developed countries are still implementing basic prevention activities against human and animal rabies, developed countries which have already controlled urban rabies are challenged for its control in sylvatic areas. Currently available vaccines are generally effective but present high production costs, biosafety risks and…
The transmission of Chikungunya virus (CHIKV) was recently reported for the first time in Central America and Caribbean, followed by the CHIKV introduction in Brazil by the zoonotic transmission mediated by Aedes spp mosquitoes, widely distributed through the country, resulting in series of epidemiologic alerts. Besides that, in the rainforest regions of South America circulates the Mayar…
(Only some records are available in English at this moment)
The objective of this research is to evaluate the production of recombinant rabies virus glycoprotein by S2 Drosophila melanogaster cells, cultivated in two different culture media. Firstly the cells will be adapted to growth in each medium and stored as a work bank. The RVGP will be produced in kinetic assays, when the consumption of glucose, glutamine and the production of lactate will …
Using the Semliki Forest Virus (SFV) for production of recombinant proteins in mammalian cells or to therapeutic and vaccine purposes has been increasingly studied. Obtaining and using this viral vector require the execution of various stages of molecular biology and cell culture. In order to establish and standardize these different methodologies we intend to use a vector able to express…
| 1 / 1 | Ongoing research grants |
| 5 / 5 | Completed research grants |
| 9 / 3 | Completed scholarships in Brazil |
| 15 / 9 | All research grants and scholarships |
| Associated processes | |
CV Lattes
ORCID